Treatment of retroviral infections with oxyphenbutazone

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/415 (2006.01) A61K 31/4152 (2006.01) A61K 31/495 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2352423

The invention provides a method of treatment of a human or non-human mammal subject to combat a retroviral infection, said method comprising administering to said subject an antivirally effective amount of a compound selected from oxyphenbutazone and other substituted-phenyl phenbutazones and substituted- phenyl prodrugs for oxyphenbutazone and other substituted phenyl phenbutazones.

L'invention se rapporte à une méthode de traitement d'un sujet mammifère humain ou non humain visant à combattre une infection rétrovirale. Ladite méthode consiste à administrer audit sujet une quantité efficace d'un point de vue antiviral d'un composé sélectionné parmi l'oxyphenbutazone et d'autres phenbutazones à substitution phényle ainsi que des promédicaments à substitution phényle destinés à former de l'oxyphenbutazone et d'autres phenbutazones à substitution phényle.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of retroviral infections with oxyphenbutazone does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of retroviral infections with oxyphenbutazone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of retroviral infections with oxyphenbutazone will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1731006

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.